Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Manipal Hospitals closes in to acquire Medanta stake at enterprise valuation 6000 crore

      Manipal Hospitals closes in to acquire Medanta stake at enterprise valuation 6000 crore

      Medical Dialogues Bureau23 Nov 2018 3:37 PM IST
      New Delhi: Manipal Hospital backed up by its investors TPG Capital and Temasek is heading closer to acquire Medanta Hospitals at a valuation of Rs...
      Glenmark gets USFDA nod for pneumonia treatment drug

      Glenmark gets USFDA nod for pneumonia treatment drug

      Medical Dialogues Bureau23 Nov 2018 12:15 PM IST
      New Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and...
      Strides Pharma board approves USD 15 million investment in Stelis Biopharma

      Strides Pharma board approves USD 15 million investment in Stelis Biopharma

      Medical Dialogues Bureau23 Nov 2018 12:14 PM IST
      New Delhi: Strides Pharma Science Thursday said its board has approved plans to invest another USD 15 million in its biotech arm Stelis Biopharma. The...
      Microsoft Launcher 5.1 adds digital health features on Android

      Microsoft Launcher 5.1 adds digital health features on Android

      Medical Dialogues Bureau23 Nov 2018 9:55 AM IST
      Washington: Microsoft is not budging from introducing new tools and features to fight Google's popular services. In its latest attempt at luring more...
      HP: Integrated Health Information Platform- IHIP for Disease Surveillance launched

      HP: Integrated Health Information Platform- IHIP for Disease Surveillance launched

      Medical Dialogues Bureau23 Nov 2018 9:00 AM IST
      With the IHIP, All the authentic information required in the health department would be available in one place for ease of patients, data users as...
      Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

      Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

      Medical Dialogues Bureau22 Nov 2018 4:37 PM IST
      NEW DELHI: Piramal Enterprises on Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on...
      Lupin launches generic Tetrabenazine Tablets

      Lupin launches generic Tetrabenazine Tablets

      Medical Dialogues Bureau22 Nov 2018 4:26 PM IST
      Mumbai: Pharma major Lupin announced the launch of Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food...
      2-billion Dollar Indian health empire run by four sisters makes a comeback-Bloomberg Report

      2-billion Dollar Indian health empire run by four sisters makes a comeback-Bloomberg Report

      Medical Dialogues Bureau22 Nov 2018 11:55 AM IST
      New Delhi: Next to Suneet a Reddy’s desk in the executive suite of Apollo Hospitals Enterprise Ltd. hangs an icon of Hinduism’s many-armed warrior...
      Medtronic reports 6 percent rise in quarterly revenue

      Medtronic reports 6 percent rise in quarterly revenue

      Medical Dialogues Bureau22 Nov 2018 9:32 AM IST
      New Delhi: Medical device maker Medtronic plc reported a 6 per cent rise in quarterly revenue on Tuesday, helped by higher sales in its cardiac and...
      Dr. Reddy

      Dr. Reddy's shares spike after favourable generic drug ruling

      Medical Dialogues Bureau22 Nov 2018 9:21 AM IST
      New Delhi: Shares of Indian drugmaker Dr. Reddy's Laboratories Ltd jumped nearly 9 per cent on Wednesday, their sharpest intraday gain in a year after...
      Roche-AbbVie cancer drug, Venclexta gets accelerated FDA approval

      Roche-AbbVie cancer drug, Venclexta gets accelerated FDA approval

      Medical Dialogues Bureau22 Nov 2018 9:15 AM IST
      New Delhi: Roche Holding AG said on Wednesday its cancer drug, Venclexta, received accelerated approval from the U.S. Food and Drug Administration as...
      FDA approves new blood cancer treatment from Pfizer

      FDA approves new blood cancer treatment from Pfizer

      Medical Dialogues Bureau22 Nov 2018 9:15 AM IST
      The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok